Sunlight Active Drug Ingredients Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
- Paid Up Capital ₹ 3.58 Cr
- Company Age 10 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 36.28 Cr
- Satisfied Charges ₹ 9.00 M
- Revenue Growth 91.11%
- Profit Growth -18.50%
- Ebitda 62.04%
- Net Worth 11.17%
- Total Assets 53.29%
About Sunlight Active Drug Ingredients
Sunlight Active Drug Ingredients Private Limited (SADIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 03 December 2014 and has a history of Ten years and two months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 3.58 Cr.
The company currently has active open charges totaling ₹36.28 Cr. The company has closed loans amounting to ₹9.00 M, as per Ministry of Corporate Affairs (MCA) records.
Venkateswara Talupula and Sravya Talupula serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24233TG2014PTC096658
-
Company No.
096658
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Dec 2014
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Sunlight Active Drug Ingredients?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkateswara Talupula
|
Managing Director | 03-Dec-2014 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Sravya Talupula
|
Director | 24-Jul-2015 | Current |
Financial Performance of Sunlight Active Drug Ingredients.
Sunlight Active Drug Ingredients Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 91.11% increase. The company also saw a substantial fall in profitability, with a 18.5% decrease in profit. The company's net worth Soared by an impressive increase of 11.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sunlight Active Drug Ingredients?
In 2023, Sunlight Active Drug Ingredients had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Organo Metallics Private LimitedVenkateswara Talupula is a mutual person
-
Guardinor Api Private Limited
Venkateswara Talupula and Sravya Talupula are mutual person
Charges (Loans)
₹36.28 Cr
₹0.90 Cr
Charges Breakdown by Lending Institutions
- Others : 35.71 Cr
- Hdfc Bank Limited : 0.57 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Apr 2023 | Hdfc Bank Limited | ₹5.69 M | Open |
| 06 Nov 2021 | Others | ₹23.52 Cr | Open |
| 29 Sep 2021 | Others | ₹6.00 M | Open |
| 20 Aug 2018 | Others | ₹11.41 Cr | Open |
| 30 Mar 2017 | Others | ₹1.75 M | Open |
How Many Employees Work at Sunlight Active Drug Ingredients?
Sunlight Active Drug Ingredients has a workforce of 8 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sunlight Active Drug Ingredients, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunlight Active Drug Ingredients's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
